Healix Infusion Care
Healix Infusion Care operates a US network of ambulatory infusion centers delivering 80+ physician-prescribed IV therapies to chronic-condition patients, with referral-based intake, in-house prior authorization handling, and a no-facility-fee billing model approximately 50% below hospital outpatient settings; acquired by Singlepoint Healthcare in 2026.
- Company typePrivate
- Founded1989
- HeadquartersSt Louis, United States
- Headcount—
- GTM typeB2B
- OfferingServices
What Healix Infusion Care does
Healix Infusion Care (legal entity: Healix, LLC, Texas) is an outpatient healthcare services company that operates a network of ambulatory infusion centers (AICs) across multiple US states, delivering physician-prescribed intravenous therapies in a non-hospital clinical setting. With 35+ years of operating history and a headquarters in Sugar Land, Texas, the company administers a portfolio of 80+ infusion products spanning monoclonal antibodies, IVIg immune globulin products, IV antibiotics/antivirals/antifungals, iron replacement therapies, and supportive care for conditions including multiple sclerosis, myasthenia gravis, rheumatoid arthritis, Crohn's disease, ulcerative colitis, primary immunodeficiency, migraine, HIV, osteoporosis, and COVID-19 prevention.
The service model is built on a no-facility-fee billing structure that produces approximately 50% lower total cost than hospital outpatient infusion centers, a positioning actively reinforced by insurance payors' site-of-care restriction policies. Operations depend on a physician-referral go-to-market with intake via fax, a FormStack secure online portal, and direct contact; Healix handles insurance benefit verification and prior authorization on behalf of patients and referring providers. Clinical operations rely on standardized standing treatment orders and therapy-specific order forms reviewed by medical leadership, plus multi-supplier pharmaceutical relationships ensuring reliable access to IVIg and biologic products.
Healix was acquired by Singlepoint Healthcare in 2026 to expand national infusion capabilities and continues to operate under the Healix Infusion Care brand. Revenue is generated through insurance reimbursement for medication administration and clinical services. HIPAA compliance governs patient health information handling, and the company maintains an active content/blog presence plus social media channels across LinkedIn, Facebook, Twitter/X, YouTube, and Instagram for patient and provider outreach.
Healix Infusion Care firmographics
Firmographics- Name
- Healix Infusion Care
- Legal name
- Healix, LLC
- Website
- https://healixinfusion.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Short description
- Healix Infusion Care operates a US network of ambulatory infusion centers delivering 80+ physician-prescribed IV therapies to chronic-condition patients, with referral-based intake, in-house prior authorization handling, and a no-facility-fee billing model approximately 50% below hospital outpatient settings; acquired by Singlepoint Healthcare in 2026.
- Ownership category
- akta.pro rank
Healix Infusion Care industry classification
Industry- Product category
- Outpatient Infusion Therapy Services
- NAICS
- Outpatient Care Centers (6214), All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
- akta.pro primary industry
- Infusion Therapy Centers (Outpatient) (HLAFABAF)
- akta.pro secondary industry
- Home Infusion Therapy Providers (HLAFAEAE)
Keywords
Where Healix Infusion Care is headquartered
LocationHeadquarters
- HQ city
- St Louis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Healix Infusion Care business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Infusion Therapy Services: Healix generates revenue through providing outpatient infusion therapy services. The company bills insurance payors for medication administration and clinical services. No facility fees are charged, unlike hospital-owned infusion centers, which reduces patient out-of-pocket costs while maintaining payer relationships.
- Insurance Reimbursement: Revenue is primarily collected through insurance reimbursements. Healix works with multiple insurance providers and handles prior authorization and benefits verification on behalf of patients to ensure coverage continuity.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Healix Infusion Care product offering
Product offeringCore offering
Healix Infusion Care delivers outpatient infusion therapy services through a national network of ambulatory infusion centers (AICs), administering physician-prescribed biologic therapies, IVIg, IV antibiotics, iron infusions, and other intravenous treatments in a clinical outpatient setting. The company supports the full service process including referral intake, insurance benefit verification, prior authorization, medication administration by infusion nurses, and ongoing care coordination, with no facility fees charged.
Product overview
Healix Infusion Care operates a network of ambulatory infusion centers providing outpatient infusion therapy services. The company offers a comprehensive portfolio of over 80 infusion therapies including monoclonal antibodies, immune globulin products (IVIg), antibiotics, antivirals, antifungals, iron therapies, and supportive care. Key therapy categories include biologics for autoimmune conditions (such as Rituxan, Ocrevus, Vyvgart), immune globulin products (Gammagard, Gamunex, Octagam, Panzyga, Bivigam), IV antibiotics (Zerbaxa, Xerava, Vibativ, Vabomere), and specialized treatments for neurological conditions. The service model focuses on administering physician-prescribed infusion medications in a cost-effective outpatient setting, handling insurance verification, prior authorizations, and providing clinical support.
Differentiator
Problem solved
Functional benefit
Products and services
- Outpatient Infusion Therapy Services
Quantifiable outcome
- Approximately 50% lower cost compared to hospital outpatient infusion centers
- +2 more outcomes
Companies that use Healix Infusion Care
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Healix Infusion Care technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature3 records
Healix Infusion Care partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Singlepoint HealthcaremajorSinglepoint Healthcare completed the acquisition of Healix Infusion Care, expanding Singlepoint's national infusion capabilities. This acquisition represents a significant strategic expansion combining Healix's 35+ years of infusion care expertise with Singlepoint Healthcare's platform.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Healix Infusion Care competitors and assessment
Company assessmentDirect peers
- Medix Infusion: Ambulatory infusion center operator offering biologic and specialty infusions across multiple states. Competes head-to-head with Healix in the AIC site-of-care model.
- PromptCare: Specialty infusion and home infusion provider serving patients with chronic conditions. Comparable in referral-driven GTM and specialty-biologic therapy portfolio.
- Vivo Infusion: Ambulatory infusion center operator with multiple locations across the U.S., specializing in biologics and chronic-condition infusions. Directly comparable site-of-care and therapy mix to Healix.
- Coram (CVS Health): CVS Health-owned national home infusion and specialty pharmacy provider. Competes with Healix in alternate-site infusion therapy administration for chronic and complex conditions.
- Option Care Health: Largest U.S. provider of home and alternate-site infusion services. Directly comparable to Healix as a national ambulatory/home infusion operator serving the same chronic-condition patient base with biologic and specialty therapies.
- Soleo Health: Specialty infusion services company operating across multiple states, focused on chronic and complex conditions. Closely comparable in therapy breadth, referral model, and payor relationships.
Broad incumbents
- DaVita: Large outpatient dialysis and integrated kidney-care provider. While not a direct infusion competitor, it operates an analogous outpatient specialty-treatment center network and competes for payor specialty-care dollars.
- BrightSpring Health Services: Diversified home and community-based health services provider including specialty infusion and pharmacy services. Comparable as a broader incumbent in the alternate-site infusion ecosystem.
- US Renal Care (Biologic Infusion / In-Center Adjacencies): Outpatient specialty care provider operating treatment centers; overlaps conceptually with Healix as a payor-friendly outpatient site-of-care for chronic specialty therapies.
Emerging players
- Nufactor: Specialty pharmacy and infusion provider focused on immune globulin (IVIg/SCIg) and related therapies. Overlaps with Healix on the IVIg distribution and immunoglobulin therapy categories.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Healix Infusion Care social profiles
Digital presenceHealix Infusion Care compliance and trust
Trust signalCompliance1 record
Healix Infusion Care financial estimates
Financial estimateRevenue estimate
Valuation estimate
Healix Infusion Care leadership team
Management profileNumber of profiles
Healix Infusion Care funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Healix Infusion Care M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Healix Infusion Care
What does Healix Infusion Care do?
Healix Infusion Care delivers outpatient infusion therapy services through a national network of ambulatory infusion centers (AICs), administering physician-prescribed biologic therapies, IVIg, IV antibiotics, iron infusions, and other intravenous treatments in a clinical outpatient setting. The company supports the full service process including referral intake, insurance benefit verification, prior authorization, medication administration by infusion nurses, and ongoing care coordination, with no facility fees charged.
Is Healix Infusion Care a public or private company?
Healix Infusion Care is a private company. It is classified as corporate owned and is currently operating.
When was Healix Infusion Care founded?
Healix Infusion Care was founded in 1989.
Where is Healix Infusion Care based?
Healix Infusion Care is headquartered in St Louis, United States, in the North America region.
How does Healix Infusion Care make money?
Two revenue lines are on record. Infusion Therapy Services are the primary driver. The others are insurance Reimbursement.
Who are Healix Infusion Care's main competitors?
Direct peers on record are Medix Infusion, PromptCare, Vivo Infusion, Coram (CVS Health), Option Care Health and Soleo Health. Broad incumbents are DaVita, BrightSpring Health Services and US Renal Care (Biologic Infusion / In-Center Adjacencies). Nufactor is listed as an emerging player.
Does Healix Infusion Care have an API?
No public API is recorded for Healix Infusion Care.
What industry is Healix Infusion Care in?
Healix Infusion Care's product category is Outpatient Infusion Therapy Services. Its primary akta.pro industry code is HLAFABAF, Infusion Therapy Centers (Outpatient), with a secondary code of HLAFAEAE, Home Infusion Therapy Providers. Its NAICS code is 6214 and its SIC code is 8093.